Latest / Washington DC News Today | 2 Min News | The Daily News Now!
FDA Approves First Oral Cholesterol Pill | Washington DC News
FDA just approved Lipfendra, the first daily oral PCSK9 inhibitor pill, offering a game-changing alternative to weekly injections for lowering dangerous cholesterol levels. With dramatic reductions in LDL cholesterol seen in trials, this Merck drug could help millions combat heart disease — the top killer in the U.S. — by making treatment more convenient and accessible. Priced at $10.50 a day, it’s poised to reach patients soon and could become a vital new tool in the fight against strokes and heart attacks. Thank you to our sponsor Garrett Waller Performance…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.